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Summary
Background Studies have suggested that the prevalence of dementia is lower in developing than in developed regions. 
We investigated the prevalence and severity of dementia in sites in low-income and middle-income countries 
according to two deﬁ nitions of dementia diagnosis.
Methods We undertook one-phase cross-sectional surveys of all residents aged 65 years and older (n=14 960) in 11 sites 
in seven low-income and middle-income countries (China, India, Cuba, Dominican Republic, Venezuela, Mexico, 
and Peru). Dementia diagnosis was made according to the culturally and educationally sensitive 10/66 dementia 
diagnostic algorithm, which had been prevalidated in 25 Latin American, Asian, and African centres; and by 
computerised application of the dementia criterion from the Diagnostic and Statistical Manual of Mental Disorders 
(DSM IV). We also compared prevalence of DSM-IV dementia in each of the study sites with that from estimates in 
European studies.
Findings The prevalence of DSM-IV dementia varied widely, from 0·3% (95% CI 0·1–0·5) in rural India to 6·3% 
(5·0–7·7) in Cuba. After standardisation for age and sex, DSM-IV prevalence in urban Latin American sites was 
four-ﬁ fths of that in Europe (standardised morbidity ratio 80 [95% CI 70–91]), but in China the prevalence was only 
half (56 [32–91] in rural China), and in India and rural Latin America a quarter or less of the European prevalence 
(18 [5–34] in rural India). 10/66 dementia prevalence was higher than that of DSM-IV dementia, and more consistent 
across sites, varying between 5·6% (95% CI 4·2–7·0) in rural China and 11·7% (10·3–13·1) in the Dominican 
Republic. The validity of the 847 of 1345 cases of 10/66 dementia not conﬁ rmed by DSM-IV was supported by high 
levels of associated disability (mean WHO Disability Assessment Schedule II score 33·7 [SD 28·6]).
Interpretation As compared with the 10/66 dementia algorithm, the DSM-IV dementia criterion might underestimate 
dementia prevalence, especially in regions with low awareness of this emerging public-health problem. 
Funding Wellcome Trust (UK); WHO; the US Alzheimer’s Association; and Fondo Nacional De Ciencia Y Tecnologia, 
Consejo De Desarrollo Cientiﬁ co Y Humanistico, and Universidad Central De Venezuela (Venezuela).
Background
In the 1990s, with demographic ageing proceeding rapidly 
in all regions worldwide, interest began to focus on the 
previously neglected topic of dementia in low-income and 
middle-income countries (LMIC). Two-thirds of all people 
aged 65 years and older, and a similar proportion of people 
with dementia, were living in LMIC, with rapid increases 
predicted.1 However, two studies funded by the National 
Institute of Aging from that period—the US-Nigeria 
study2 and the Indo-US study3—suggested an age-speciﬁ c 
prevalence of dementia that was only between a quarter 
and a ﬁ fth of that typically recorded in developed countries. 
Longitudinal data from the same centres suggested that 
these ﬁ ndings were because of a decreased incidence of 
disease, rather than reduced survival alone.4,5
In 2005, Alzheimer’s Disease International (ADI) 
commissioned an international group of experts to 
review all available data and to reach a consensus on 
dementia prevalence in 14 WHO regions. The results 
suggested that 24·2 million people live with dementia 
worldwide, with 4·6 million new cases every year.6 The 
trend towards a lower prevalence in less-developed 
regions than in developed settings was endorsed, at least 
for sub-Saharan Africa and south Asia. Nonetheless, the 
ﬁ gures indicated that most people with dementia lived in 
LMIC: 60% in 2001 rising to a forecast 71% by 2040. 
Numbers were predicted to double every 20 years to more 
than 80 million people by 2040, with more rapid increases 
in developing than in developed regions. However, the 
quality and coverage of the evidence-base is poor, with 
very few published studies from Latin America, Africa, 
the Middle East, eastern Europe, and Russia, and patchy 
and inconsistent estimates in other less developed 
regions.6 Some new studies have been published,7–11 but 
dementia in LMIC remains under-researched. 
In 1999, the 10/66 Dementia Research Group launched 
a large-scale pilot study in 25 centres in LMIC, 
developing and validating the 10/66 dementia diagnosis 
as a tool especially suited for studies based in low 
education populations in the developing world, or those 
designed to make valid comparisons across countries 
and cultures.12 Our subsequent programme of 
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population-based cross-sectional surveys in 17 sites in 
12 developing countries (India, China, Nigeria, South 
Africa, Cuba, Dominican Republic, Brazil, Venezuela, 
Mexico, Peru, Argentina, and Puerto Rico) will provide a 
unique resource for comparative descriptive research of 
prevalence, eﬀ ect, and cost of this disease.13 An incidence 
phase, which is now in progress, focuses on aetiology, 
examining the roles of racial admixture, micronutrient 
deﬁ ciency, cardiovascular disease, and its risk factors.
We now report the prevalence of dementia in the ﬁ rst 
group of 10/66 sites (India, China, Cuba, Dominican 
Republic, Venezuela, Mexico, and Peru). Results from 
the Brazilian site have already been published,11 and 
data from the remaining sites should become available 
in 2009. We aimed to address the following four 
questions: ﬁ rst, how do the prevalences and severity of 
dementia, deﬁ ned by the 10/66 group and the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-IV), 
vary between sites and regions when estimated with the 
same cross-culturally validated methods, and how much 
of that variation can be explained by compositional 
(demographic ageing, education, and socioeconomic 
status) and methodological factors? Second, how does 
the 10/66 diagnosis of dementia compare with the 
DSM-IV dementia criterion that was used in many 
previous LMIC studies, and what is their construct 
validity with respect to concurrent associations with 
disability? Third, how do our ﬁ ndings for DSM-IV 
dementia prevalence compare with the consistent 
prevalence of dementia in Europe?14 Finally, how 
consistent are our new ﬁ ndings with the regional 
estimates from the ADI and Lancet consensus study?6
Methods
Settings and study design
The full 10/66 population-based study protocols have 
already been published elsewhere.13 This study was 
undertaken in 11 geographically deﬁ ned catchment area 
sites in seven LMIC (India, China, Cuba, Dominican 
Republic, Venezuela, Mexico, and Peru). We undertook 
cross-sectional comprehensive one-phase surveys of all 
residents aged 65 years and older. After visiting people’s 
homes to establish eligibility, all those consenting to 
participate received the full assessment lasting 2–3 h, 
consisting of participant and informant interviews, 
physical examination, and phlebotomy. Interviews were 
done in participants’ homes. Participants provided 
written consent. Next of kin provided written agreement 
in the event of lack of capacity to consent. Illiterate 
participants provided oral consent that was witnessed in 
writing by a literate person.
The target sample size for every country was 
2000–3000 participants (table 1). Recruitment in China, 
India, Peru, and Mexico was split between urban and 
rural sites; all other countries included urban sites only. 
A sample size of 2000 would allow estimation of a typical 
dementia prevalence of 4·5% (standard error 0·9%).14 
Rural and urban samples of 1000 each would provide a 
standard error of 1·2%. All studies were approved by 
local ethics committees and the King’s College London 
(UK) ethics committee.
Protocols and procedures
Every site had a project coordinator and between four 
and ten interviewers who were generally non-specialist 
graduates, although Cuba and China used medical 
doctors. Assessments were translated into Ibero-
American Spanish (with country-speciﬁ c adaptations 
when necessary), Tamil (India), and Mandarin (China). 
Personnel at all centres had already been extensively 
trained in the main diagnostic assessments for the 
dementia diagnostic pilot study.12 An extra 1 week of 
project planning meetings were held for all principal 
investigators before starting ﬁ eldwork. Group meetings 
for investigators from all sites were held roughly every 
6 months throughout the project. All researchers were 
retrained in study protocol and procedures and structured 
interviewing techniques, and were supported by a 
standardised operating procedures manual. All interviews 
were checked by the project coordinator for completeness 
and coherence before data entry. Every interviewer was 
supervised in the ﬁ eld until the coordinator was satisﬁ ed 
with interview quality. Random checks were made every 
few months thereafter. The London-based coordinators 
(CPF and MP) visited every centre at least twice during 
the ﬁ eldwork phase. In Cuba, data were collected directly 
onto laptop computers with computerised question naires 
driven by EpiData (version 2.0) software, incorporating 
conditional skips and range checks. In other sites, data 
were ﬁ rst collected onto paper. Data were extracted into 
SPSS (version 15.0), and cleaning, processing of derived 
variables, and diagnostic algorithms were done with 
SPSS syntax ﬁ les. Data were checked in London after the 
ﬁ rst 100 interviews had been completed, and on three to 
four occasions subsequently.
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Site Setting Achieved sample 
(completed interviews)
Response 
proportion
Cuba (JLR) Havana/Matanzas Urban 2944 94%
Dominican Republic (DA) Santo Domingo Urban 2011 95%
Peru (MG) Lima Urban 1381 80%
Canete Rural 552 88%
Venezuela (AS) Caracas Urban 1904 80%
Mexico (ALS) Mexico City Urban 1002 84%
Morelos Rural 1000 86%
China (SL, YH) Xicheng, Beijing Urban 1160 74%
Daxing Rural 1002 96%
India (ESK, KSJ) Chennai Urban 1005 72%
Vellore Rural 999 98%
Overall 11 sites 7 urban, 4 rural 14 960
Initials of the principal investigator are shown in parentheses.
Table 1: Summary of the sites and samples
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Measures
The 10/66 population-based study interview generates 
information about dementia diagnosis, mental 
disorders, physical health, anthropometry, demographics, 
an extensive dementia and chronic diseases risk factor 
questionnaire, disability, health-service use, care arrange-
ments, and caregiver strain.13 In the Latin American 
sites, we analysed fasting blood samples for full blood 
count and diﬀ erential glucose, cholesterol, triglyceride, 
and albumin measurements. Frozen serum was saved. 
DNA was extracted and will be analysed for 
apolipoprotein genotype and African/European ancestry 
admixture. We describe in detail here only the 
assessments relevant to the present descriptive analysis 
of dementia prevalence. 
Age of the participant was formally established during 
interview from stated age, oﬃ  cial documentation, 
informant report, and, in the case of discrepancy, age 
according to an event calendar. We also recorded sex 
and marital status. We obtained similar demographic 
information about informants.
We recorded the following socioeconomic variables: 
level of education (none/did not complete primary/
completed primary/secondary/tertiary); sources and 
amount of income; household assets index (car, television, 
refrigerator, telephone, mains water, plumbed toilet); and 
food insecurity (assessed by the question “do you ever go 
hungry because there is not enough food to eat?”).
We measured activity limitation and participation 
restriction by the WHO Disability Assessment Schedule 
Cuba 
(N=2944)
Dominican 
Republic 
(N=2011)
Peru (urban) 
(N=1381)
Peru
(rural) 
(N=552)
Venezuela 
(N=1904)
Mexico 
(urban) 
(N=1002)
Mexico 
(rural) 
(N=1000)
China 
(urban) 
(N=1160)
China 
(rural) 
(N=1002)
India 
(urban) 
(N=1005)
India (rural) 
(N=999)
Demographic variables
Age (years)
65–69 760 (25·9%) 533 (26·5%) 375 (27·2%) 179 (32·4%) 813 (42·7%) 245 (24·4%) 299 (29·9%) 316 (27·2%) 383 (38·2%) 415 (41·5%) 331 (33·1%)
70–74 789 (26·9%) 520 (25·9%) 25·5 (52·7%) 141 (25·5%) 461 (24·2%) 329 (32·8%) 252 (25·2%) 362 (31·2%) 296 (29·5%) 318 (31·8%) 350 (35·0%)
75–79 639 (21·8%) 397 (19·7%) 298 (21·6%) 101 (18·3%) 340 (17·9%) 205 (20·5%) 221 (22·1%) 254 (21·9%) 202 (20·2%) 144 (14·4%) 177 (17·7%)
≥80 749 (25·5%) 561 (27·9%) 355 (25·7%) 131 (23·7%) 290 (15·2%) 223 (22·3%) 228 (22·8%) 228 (19·7%) 121 (12·1%) 124 (12·4%) 141 (14·1%)
Missing 7 0 1 0 0 1 0 0 0 4 0
Women 1913 (65·0%) 1325 (66·0%) 888 (64·3%) 295 (53·4%) 1215 (63·8%) 666 (66·4%) 602 (60·2%) 661 (57·0%) 556 (55·5%) 571 (57·7%) 545 (54·5%)
Missing values 0 2 0 0 0 0 0 0 0 15 0
Marital status
Never married 275 (9·4%) 139 (7·0%) 145 (10·6%) 68 (12·3%) 188 (9·9%) 63 (6·3%) 42 (4·2%) 3 (0·3%) 22 (2·2%) 21 (2·1%) 5 (0·5%)
Married/cohabiting 1271 (43·3%) 586 (29·4%) 784 (57·2%) 308 (55·9%) 903 (47·7%) 470 (46·9%) 538 (53·8%) 829 (71·7%) 585 (58·4%) 523 (52·2%) 481 (48·2%)
Widowed 928 (31·6%) 806 (40·4%) 367 (26·8%) 157 (28·5%) 544 (28·8%) 395 (39·4%) 371 (37·1%) 326 (28·1%) 394 (39·3%) 426 (42·5%) 497 (49·7%)
Divorced/separated 462 (15·7%) 465 (23·3%) 75 (5·5%) 18 (3·3%) 257 (13·6%) 75 (7·5%) 48 (4·8%) 2 (0·2%) 1 (0·1%) 32 (3·2%) 16 (1·6%)
Missing values 8 15 10 15 12 0 1 0 0 3 0
Education
None 75 (2·5%) 392 (19·7%) 37 (2·7%) 84 (15·4%) 154 (8·1%) 227 (22·6%) 327 (32·7%) 232 (20·0%) 579 (57·8%) 428 (42·7%) 660 (66·1%)
Minimal 655 (22·3%) 1022 (51·3%) 90 (6·5%) 141 (25·9%) 438 (23·1%) 354 (35·3%) 510 (51·0%) 153 (13·2%) 114 (11·4%) 234 (23·3%) 195 (19·5%)
Completed primary 979 (33·3%) 370 (18·6%) 460 (33·5%) 267 (49·1%) 950 (50·1%) 229 (22·8%) 122 (12·2%) 303 (26·1%) 259 (25·8%) 212 (21·1%) 116 (11·6%)
Completed 
secondary
728 (24·8%) 135 (6·8%) 481 (35·0%) 36 (6·6%) 263 (13·9%) 99 (9·9%) 25 (2·5%) 335 (28·9%) 45 (4·5%) 87 (8·7%) 26 (2·6%)
Tertiary 499 (17·0%) 73 (3·7%) 305 (22·2%) 16 (2·9%) 92 (4·8%) 94 (9·4%) 16 (1·6%) 137 (11·8%) 5 (0·5%) 42 (4·2%) 2 (0·2%)
Missing values 8 19 8 8 7 0 0 0 0 2 0
Socioeconomic position
Government or 
occupational pension 
disclosed
2417 (82·1%) 611 (30·4%) 908 (65·7%) 357 (64·7%) 1128 (59·2%) 729 (72·7%) 254 (25·4%) 1050 (90·5%) 38 (3·8%) 117 (11·6%) 346 (34·6%)
Food insecurity 140 (4·8%) 240 (12·1%) 63 (4·6%) (74 (13·5%) 109 (5·9%) 39 (3·9%) 85 (8·6%) 0 12 (1·2%) 207 (20·8%) 141 (14·1%)
Missing values 11 22 16 5 69 4 7 0 0 10 0
Number of assets
0–2 29 (1·0%) 136 (6·8%) 5 (0·4%) 38 (6·9%) 4 (0·2%) 13 (1·3%) 213 (21·3%) 0 (0·0%) 15 (1·5%) 132 (13·2%) 444 (44·4%)
3–5 1008 (34·3%) 951 (47·4%) 61 (4·4%) 343 (62·1%) 9 (0·5%) 150 (15·0%) 518 (51·8%) 604 (52·1%) 374 (37·3%) 620 (61·9%) 512 (51·3%)
6 1899 (64·7%) 919 (45·8%) 1315 (95·2%) 171 (31·0%) 1860 (99·3%) 840 (83·7%) 269 (26·9%) 555 (47·9%) 613 (61·2%) 249 (24·9%) 43 (4·3%)
Missing values 8 5 0 0 31 0 0 1 0 4 0
Data are number (%).
Table 2: Demographic and socioeconomic characteristics by study site
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(WHODAS) II,15 which was developed by WHO as a 
culture-fair assessment for cross-cultural research.
10/66 dementia diagnosis was given to participants 
scoring above a cutpoint of predicted probability for 
dementia, which was calculated with coeﬃ  cients derived 
from a logistic regression equation that was developed, 
calibrated, and validated cross-culturally in the 10/66 
pilot study undertaken in 25 centres.12 The coeﬃ  cients 
are linked to the outputs from a structured clinical 
mental-state interview: the Geriatric Mental State;16 two 
cognitive tests: the Community Screening Instrument 
for Dementia (CSI’D’) COGSCORE17 and the modiﬁ ed 
CERAD ten-word list learning task with delayed recall;18 
and informant reports of cognitive and functional decline 
from the CSI’D’ RELSCORE.17 In the pilot study, this 
algorithm was developed on half the sample and tested 
on the other, and identiﬁ ed dementia with a sensitivity 
of 94% and speciﬁ city of 97% in controls with high-level 
education and a speciﬁ city of 94% in those with low-level 
education.12
DSM-IV dementia diagnosis was allocated to those 
meeting the relevant criteria:19 impairment in memory 
and at least one other domain of cognitive function; 
impairment in social or occupational functioning, and 
representing a decrease from a previous level of 
functioning; not occurring exclusively during delirium; 
and not better accounted for by another mental disorder. 
Our fully operationalised computerised algorithm has 
been published elsewhere.20 It addresses a key weakness 
of dementia diagnosis with the DSM systems—that 
insuﬃ  cient operationalisation leads to poor reliability 
for speciﬁ c elements,21 more so between than within 
65–69 years 70–74 years 75–79 years ≥80 years Crude prevalence 
(95% CI)
Standardised 
prevalence (95% CI)*
Cuba
Men 2·9% (0·9–5·0) 5·9% (3·1–8·6) 6·6% (3·3–9·8) 23·2% (17·7–28·6) 10·8% (9·7–11·9) 12·6% (10·4–14·9)
Women 2·9% (1·4–4·4) 6·1% (4·0–8·2) 9·8% (6·9–12·7) 26·6% (22·8–30·5)
Dominican Republic
Men 4·8% (1·7– 7·9) 6·2% (2·7– 9·6) 14·4% (8·3–20·5) 17·2% (11·4–22·9) 11·7% (10·3–13·1) 9·8% (8·4–11·1)
Women 3·5% (1·5–5·4) 7·1% (4·3–9·9) 11·7% (7·8–15·6) 25·5% (21·2–29·8)
Peru (urban)
Men 3·6% (0·1–7·1) 3·0% (0·1– 6·0) 8·3% (3·0–13·6) 19·3% (12·8–25·8) 9·3% (7·7–11·0) 8·5% (6·2–10·8)
Women 2·3% (0·04–4·1) 2·2% (0·0–4·3) 7·9% (4·0–11·8) 27·2% (21·0–33·5)
Peru (rural)
Men 1·3% (0·0–3·8) 3·5% (0·0–8·3) 8·3% (0·2–16·4) 6·9% (0·1–13·0) 6·5% (4·4–8·6) 7·6% (5·0–10·3)
Women 5·0% (0·6–9·3) 7·2% (1·5–12·9) 5·7% (0·0–12·1) 17·0% (7·1–26·8)
Venezuela
Men 3·0% (1·1– 4·9) 2·3% (0·0–4·5) 6·5% (2·1–10·8) 17·2% (9·1–25·4) 5·7% (4·7–6·8) 6·2% (4·9–7·4)
Women 2·0% (0·8– 3·2) 3·5% (1·4– 5·6) 5·1% (2·1–8·1) 20·7% (15·1–26·3)
Mexico (urban)
Men 0 5·1% (1·1– 9·1) 3·8% (0·0–8·1) 16·3% (7·5–25·0) 8·6% (6·8–10·4) 7·4% (5·9–8·9)
Women 0·5% (0·0–1·6) 4·3% (1·5–7·0) 13·5% (7·4–19·5) 25·2% (18·1–32·3)
Mexico (rural)
Men 0 2·9% (0·0–6·2) 6·9% (1·5–12·3) 20·7% (12·9–28·6) 8·5% (6·7–10·3) 7·3% (5·7–9·0)
Women 2·0% (0·1–4·0) 6·0% (2·2–9·9) 9·7% (4·6–14·8) 22·9% (15·3–30·6)
China (urban)
Men 0 3·7% (0·7–6·7) 6·0% (1·6–10·3) 14·7% (7·9–21·4) 7·0% (5·5–8·5) 8·0% (6·2–9·8)
Women 2·9% (0·6–5·3) 3·0% (0·6–5·3) 8·0% (3·4–12·6) 24·4% (16·5–32·2)
China (rural)
Men 1·6% (0·0–3·3) 3·1% (0·0–6·0) 9·1% (2·5–15·6) 19·6% (7·6–31·5) 5·6% (4·2–7·0) 4·8% (3·1–6·4)
Women 1·6% (0·0–3·3) 4·2% (1·1–7·3) 9·6% (4·4–14·8) 14·7% (6·5–22·9)
India (urban)
Men 2·9% (0·4– 5·4) 5·5% (1·5–9·6) 4·5% (0·0–9·6) 25·0% (12·8–37·2) 7·5% (5·8–9·1) 8·2% (6·0–10·3)
Women 5·5% (2·5–8·4) 7·4% (3·6–11·2) 8·0% (1·7–14·3) 21·2% (11·0–31·4)
India (rural)
Men 4·3% (0·9–7·7) 5·8% (2·1– 9·6) 5·7% (0·7–10·6) 11·0% (3·6–18·3) 10·6% (8·6–12·6) 8·7% (6·9–10·5)
Women 7·8% (4·0–11·6) 14·8% (9·8–19·8) 15·7% (8·0–23·5) 29·4% (18·3–40·5)
Webtable 1 shows distribution of sample and 10/66 dementia cases by age and sex. *Standardised for age, sex, and education.
Table 3: Prevalence (95% CI) of 10/66 dementia by age group, sex, and country
See Online for webtable 1
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international research teams.22 We assessed the severity 
of dementia (classiﬁ ed as questionable, mild, moderate, 
or severe) in all participants according to the clinical 
dementia rating (CDR).23 The full syntax ﬁ les for the 
algorithms for 10/66 Dementia, DSM-IV dementia, and 
CDR can be accessed on the 10/66 website.
Statistical analysis
We used the 10/66 data archive (release 1.5; February, 2008) 
and STATA (version 9.2) for all analyses. For every site we 
described the participants’ characteristics: age, sex, 
marital status, educational level, receipt of government 
or occupational pension, and food security. We reported 
the prevalence of 10/66 dementia and DSM-IV dementia 
by age and sex, with robust 95% CIs adjusted for 
household clustering, and described the clinical severity 
(CDR) for dementia cases. Furthermore, we modelled 
the eﬀ ects of age, sex, education, and household assets, 
providing mutually adjusted prevalence ratios derived 
from a Poisson working model. We used the ﬁ tted model 
to estimate the increment in age corresponding to a 
doubling of estimated prevalence. We ﬁ tted the model 
separately for every site and then used a ﬁ xed eﬀ ects 
meta-analysis to combine them, with Higgins’ I2 to 
estimate the degree of heterogeneity24 with approximate 
95% CIs. 
We used standardisation to make three comparisons. 
First, to compare the prevalence of 10/66 dementia and 
DSM-IV dementia between our study sites after 
adjustment for the compositional eﬀ ects of age, sex, and 
education (direct standardisation, with the whole sample 
as the standard population). Second, to compare the 
65–69 years 70–74 years 75–79 years ≥80 years Crude prevalence 
(95% CI)
Standardised 
prevalence (95% CI)*
Cuba
Men 1·1% (0·0–2·3) 3·1% (1·1– 5·1) 3·9% (1·4– 6·4) 13·7% (9·3–18·2) 6·4% (5·5–7·3) 6·3% (5·0–7·7)
Women 1·8% (0·6–3·1) 3·6% (2·0–5·3) 5·9% (3·6– 8·2) 16·5% (13·2–19·7)
Dominican Republic
Men 2·1% (0·0–4·2) 5·1% (2·0– 8·3) 4·5% (0·9– 8·1) 10·1% (5·5–14·6) 5·4% (4·4–6·4) 4·2% (3·3–5·1)
Women 0·9% (0·0–1·8) 3·1% (1·2– 5·0) 4·9% (2·3– 7·5) 11·7% (8·5–14·9)
Peru (urban)
Men 2·7% (0·0–5·7) 0 1·8% (0·0–4·4) 2·8% (0·0–5·6) 3·1% (2·2–4·0) 3·8% (1·9–5·8)
Women 1·5% (0·0–3·0) 1·4% (0·0–2·9) 2·6% (0·3–4·9) 9·8% (5·8–13·8)
Peru (rural)
Men 0 0 0 0 0·4% (0·1–0·9) 0·4% (0·0–1·0)
Women 0 0 0 3·4% (0·0–8·1)
Venezuela
Men 0·3% (0·0–1·0) 0 1·6% (0·0–3·9) 5·7% (0·7–10·7) 1·9% (1·3–2·6) 2·6% (1·6–3·5)
Women 0·9% (0·0–1·7) 1·0% (0·0–2·2) 2·8% (0·6–5·0) 7·9% (4·1–11·6)
Mexico (urban)
Men 0 3·4% (0·1–6·7) 2·5% (0·0–6·1) 8·7% (2·4–15·1) 4·1% (2·8–5·3) 3·2% (2·2–4·2)
Women 0·5% (0·0–1·6) 1·4% (0·0–3·0) 4·0% (0·5–0·7) 12·6% (7·1–18·1)
Mexico (rural)
Men 1·0% (0·0–2·9) 0 1·2% (0·0–3·4) 6·6% (1·8–11·4) 2·2% (1·3–3·1) 2·4% (1·2–3·6)
Women 1·0% (0·4–2·4) 2·0% (0·0–4·3) 2·2% (0·0–4·8) 4·1% (0·5–7·7)
China (urban)
Men 0·9% (0·0–2·7) 2·5% (0·1–4·9) 3·4% (0·1–6·8) 5·5% (1·2–9·8) 3·0% (2·0–4·0) 3·1% (2·0–4·2)
Women 2·0% (0·0–3·9) 0·5% (0·0–1·5) 2·2% (0·0–4·7) 10·1% (4·6–15·6)
China (rural)
Men 0·1% (0·0–1·5) 2·3% (0·0–4·9) 2·6% (0·0–6·2) 8·7% (0·2–17·1) 2·4% (1·4–3·3) 2·0% (0·8–3·1)
Women 1·6% (0·0–3·3) 1·8% (0·0–3·9) 4·8% (1·0–8·6) 2·7% (0·0–6·4)
India (urban)
Men 0·6% (0·0–1·7) 1·6% (0·0–3·8) 0 0 0·9% (0·3–1·5) 0·9% (0·3–1·6)
Women 0·8% (0·0–2·0) 1·1% (0·0–2·5) 0 3·0% (0·0–7·3)
India (rural)
Men 0·7% (0·0–2·1) 1·3% (0·0–3·1) 0 1·4% (0·0–4·1) 0·8% (0·2–1·3) 0·3% (0·1–0·5)
Women 0·5% (0·0–1·6) 1·0% (0·0–2·4) 0 1·5% (0·0–4·4)
Webtable 2 shows distribution of sample and DSM-IV dementia cases by age and sex. *Standardised for age, sex, and education.
Table 4: Prevalence (95% CI) of DSM-IV dementia by age group, sex, and country
For the 10/66 website see 
http://www.alz.co.uk/1066
See Online for webtable 2
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prevalence of DSM-IV dementia in each of the study sites 
with that from the EURODEM meta-analysis of 
12 European studies14 (indirect standardisation for age; 
sex-standardised morbidity ratios [SMR] and Fieller 
95% CIs were calculated with an SMR of 100 for the 
reference population). Third, to compare the prevalence 
of DSM-IV dementia and 10/66 dementia (restricted and 
not restricted to CDR mild, moderate, and severe cases) 
in each of the study sites and regions with that from the 
ADI and Lancet consensus study for the relevant region6 
(indirect standardisation for age).
We assessed the concurrent validity of dementia 
diagnoses with the DSM-IV and 10/66 criteria by 
comparing the distribution of WHODAS disability scores 
between participants with no dementia (group 1), those 
with 10/66 dementia not conﬁ rmed by DSM-IV (group 2), 
and those with DSM-IV dementia (group 3). We used 
zero inﬂ ated-negative binomial regression to model the 
main eﬀ ect of 10/66 dementia and 10/66 dementia by 
DSM-IV dementia interaction term on disability scores, 
after adjustment for other relevant covariates. These 
two parameters provided a test of diﬀ erences for group 2 
versus group 1, and group 3 versus group 2. 
Role of the funding source
The sponsors of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. All authors had full access to all the 
data in the study, and the corresponding author had ﬁ nal 
responsibility for the decision to submit for publication.
Results
Overall, 14 960 interviews were completed (table 1). 
Response proportions varied between 72% and 98%, and 
were 80% or higher in all but two sites (urban China and 
urban India; table 1).
Demographic ageing was more advanced in the Latin 
American centres and urban China than in rural China 
Latin America 
(urban) (N=9242)
Latin America 
(rural) (N=1552)
China (urban) 
(N=1160)
China (rural) 
(N=1002)
India (urban) 
(N=1005)
India (rural) 
(N=999)
DSM-IV dementia
Crude prevalence 4·6% (4·2–5·1) 1·5% (0·9–2·2) 3·0% (2·0–4·0) 2·4% (1·4–3·3) 0·9% (0·3–1·5) 0·8% (0·2–1·3)
Standardised prevalence* 4·4% (3·9–4·8) 1·8% (0·9–2·8) 3·1% (2·0–4·2) 2·0% (0·8–3·1) 0·9% (0·3–1·6) 0·3% (0·1–0·5)
SMR† (EURODEM)‡ 80 (70–91) 27 (16–41) 57 (36–86) 56 (32–91) 22 (7–41) 18 (5–34)
SMR (ADI/Lancet)§ 55 (49–62) 19 (11–28) 44 (28–64) 44 (25–69) 33 (11–66) 27 (8–54)
DSM-IV dementia severity
Number of cases 432 24 35 24 9 8
Questionable 8 (1·9%) 2 (8·3%) 0 0 0 0
Mild 213 (49·3%) 16 (66·7%) 15 (42·9%) 10 (41·7%) 4 (44·4%) 4 (50·0%)
Moderate 135 (31·3%) 5 (20·8%) 19 (54·3%) 13 (54·2%) 4 (44·4%) 4 (50·0%)
Severe 76 (17·6%) 1 (4·2%) 1 (2·9%) 1 (4·2%) 1 (11·1%) 0
10/66 dementia
Crude prevalence 9·7% (9·1–10·4) 7·8% (6·4–9·2) 7·0% (5·5–8·5) 5·6% (4·2–7·0) 7·5% (5·8–9·1) 10·6% (8·6–12·6)
Standardised prevalence* 9·7% (9·0–10·3) 7·4% (5·9–9·0) 8·0% (6·2–9·8) 4·8% (3·1–6·4) 8·2% (6·0–10·3) 8·7% (6·9–10·5)
SMR (ADI/Lancet)§ 116 (105–128) 97 (75–125) 102 (74–140) 102 (70–150) 278 (184–464) 358 (246–577)
10/66 dementia severity
Number of cases 906 121 81 56 75 106
No dementia 7 (0·8%) 6 (5·0%) 0 2 (3·6%) 6 (8·0%) 6 (5·7%)
Questionable 221 (24·4%) 56 (46·3%) 15 (18·5%) 16 (28·6%) 49 (65·3%) 67 (63·2%)
Mild 389 (42·9%) 46 (38·0%) 36 (44·4%) 24 (42·9%) 15 (20·0%) 27 (25·5%)
Moderate 197 (21·7%) 10 (8·3%) 28 (34·6%) 13 (23·2%) 4 (5·3%) 4 (3·8%)
Severe 92 (10·2%) 3 (2·5%) 2 (2·5%) 1 (1·8%) 1 (1·3%) 2 (1·9%)
10/66 dementia, restricted to CDR mild/moderate/severe
Crude prevalence 7·3% (6·8–7·8) 3·8% (2·9–4·7) 5·7% (4·4–7·0) 3·8% (2·6–5·0) 2·0% (1·1–2·9) 3·3% (2·2–4·4)
Standardised prevalence* 6·9% (6·2–7·3) 4·3% (2·9–5·6) 6·3% (4·7–7·8) 3·5% (2·0–4·9) 2·1% (1·1–3·0) 1·4% (0·9–1·9)
SMR (ADI/Lancet)§ 87 (78–96) 47 (34–63) 83 (59–115) 69 (44–104) 74 (38–134) 111 (66–189)
Webtable 3 shows standardised morbidity ratios for comparisons. SMR=standardised morbidity ratio. CDR=clinical dementia rating.23 *Direct standardisation for age, sex, and 
education. †SMR is a ratio of the observed to expected number of dementia cases. The observed ﬁ gures come from the 10/66 study samples, and the expected ﬁ gures from 
applying the age-speciﬁ c and sex-speciﬁ c prevalence (EURODEM)14 or age-speciﬁ c prevalence (Lancet/ADI regional consensus estimates)6 from the reference population to 
the age, or age and sex distribution of the 10/66 study samples. An SMR of 100 implies that the dementia prevalence in the 10/66 study sample is similar to that in the 
reference population, an SMR less than 100 implies that the prevalence in the 10/66 sample is lower than that in the reference population, and an SMR greater than 100 
implies that the prevalence is higher than that in the reference population. ‡Indirect standardisation for age and sex. §Indirect standardisation for age. 
Table 5: Prevalence (95% CI) of 10/66 dementia and DSM-IV dementia, by region and clinical severity, to compare prevalence from 10/66 studies with 
EURODEM DSM-IV prevalence and prevalence estimates from the ADI and Lancet consensus study
See Online for webtable 3
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and India (table 2). Educational levels were highest in the 
urban sites in Cuba, Peru, and Venezuela. In the 
Dominican Republic, rural Peru, and Mexico, between 
15% and 33% of participants had no education, whereas 
having no education in rural China and India was 
common. Women predominated over men in all sites. 
Pension coverage was especially low in the Dominican 
Republic, rural Mexico, rural China, and India; food 
insecurity was prevalent in these sites (table 2).
The prevalence of 10/66 dementia varied between 5·6% 
and 11·7% by site (table 3), whereas that of DSM-IV 
dementia varied between 0·4% and 6·4% (table 4). The 
prevalence of 10/66 dementia was higher in every site, 
and was generally around double that of DSM-IV 
dementia. However, in urban India (0·9%), rural India 
(0·8%), and in rural Peru (0·4%), the prevalence of 
DSM-IV dementia was much lower than the 10/66 
dementia prevalence in the same site (7·5%, 10·6%, 
and 6·5%, respectively). The distribution of CDR 
clinical severity was generally less severe for patients 
with 10/66 dementia than for those with DSM-IV 
dementia (table 5). Those with 10/66 dementia had a 
lower CDR severity proﬁ le in rural Latin America and 
India than in other regions. However, even after 
restricting 10/66 dementia to CDR mild, moderate, and 
severe cases, the prevalence exceeded that of DSM-IV 
dementia in all sites (table 5).
The prevalence of dementia was strongly age-dependent 
for both criteria, with pooled estimates suggesting a 
doubling with every 7·5-year increment in age (table 6). 
The prevalence of dementia was consistently lower in 
men than in women, with a pooled adjusted prevalence 
ratio of 0·84 (95% CI 0·75–0·93) for 10/66 dementia 
and 0·88 (0·73–1·05) for DSM-IV dementia. The eﬀ ect 
of education (an inverse association) predominated over 
that of assets, although assets, rather than education, 
were independently inversely associated with 10/66 
dementia prevalence in rural Mexico and in urban India. 
Direct standardisation for age, sex, and education had 
little eﬀ ect on prevalence diﬀ erences between sites. The 
standardised prevalence of 10/66 dementia was somewhat 
higher in Cuba (12·6%) and the Dominican Republic 
(9·8%), and somewhat lower in rural China (4·8%) than 
in other sites, where prevalence ranged between 6% 
10/66 dementia DSM-IV dementia
Age (5-year 
groups)
Increment in age 
for a doubling of 
estimated 
prevalence (years)
Sex Education Assets Age (5-year 
groups)
Increment in age 
for a doubling of 
estimated 
prevalence (years)
Sex Education Assets
Individual sites
Cuba 1·99
(1·76–2·26)
7·1
(6·3–8·3)
0·89
(0·71–1·11)
0·81
(0·73–0·91)
0·99
(0·89–1·10)
2·11
(1·79–2·49)
6·7
(5·8–8·0)
0·79
(0·59–1·08)
0·86
0·75–0·99)
1·02
(0·88–1·18)
Dominican Republic 1·76
(1·55–1·98)
9·1
(7·8–11·2)
0·91
(0·70–1·19)
0·83
(0·71–0·98)
0·89
(0·79–1·01)
1·82
(1·51–2·21)
8·3
(6·5–11·0)
1·13
(0·76–1·70)
0·89
(0·67–1·10)
0·97
(0·81–1·18)
Peru (urban) 2·48
(1·99–3·10)
6·0
(5·2–7·1)
0·89
(0·62–1·26)
0·90
(0·77–1·07)
1·12
(0·93–1·34)
1·87
(1·26–2·76)
7·9
(5·5–13·6)
0·54
(0·26–1·15)
0·73
(0·54–1·00)
1·37
(1·01–1·86)
Peru (rural) 1·37
(1·03–1·83)
16·1
(8·1–inﬁ nity)
0·53
(0·25–1·11)
0·69
(0·47–1·01)
0·86
(0·62–1·21)
Too few cases (two) to estimate parameters
Venezuela 2·00
(1·65–2·42)
7·5
(6·2–9·2)
1·02
(0·70–1·50)
0·79
(0·66–0·94)
0·94
(0·77–1·16)
2·19
(1·41–3·40)
8·1
(5·8–13·6)
0·61
(0·28–1·33)
0·68
(0·47–0·97)
0·88
(0·60–1·28)
Mexico (urban) 2·29
(1·81–2·89)
6·4
(5·3–8·4)
0·69
(0·44–1·07)
0·61
(0·46–0·80)
0·98
(0·82–1·16)
2·25
(1·57–3·22)
6·9
(5·1–10·3)
0·96
(0·51–1·80)
0·46
(0·33–0·64)
1·15
(0·90–1·48)
Mexico (rural) 2·32
(1·86–2·89)
6·0
(5·0–7·5)
0·77
(0·52–1·13)
0·88
(0·61–1·27)
0·76
(0·63–0·92)
1·95
(1·26–3·02)
6·2
(4·2–11·6)
0·87
(0·39–1·96)
1·47
(0·91–2·38)
1·08
(0·72–1·61)
China (urban) 2·38
(1·87–3·02)
5·3
(4·4–6·9)
0·79
(0·48–1·28)
0·80
(0·67–0·97)
1·28
(0·93–1·75)
1·92
(1·34–2·75)
6·5
(4·4–12·1)
0·94
(0·43–2·04)
0·96
(0·71–1·30)
0·80
(0·50–1·27)
China (rural) 2·21
(1·73–2·84)
6·2
(5·0–8·5)
0·94
(0·57–1·56)
1·08
(0·80–1·46)
0·90
(0·72–1·12)
1·63
(1·11–2·41)
8·4
(5·3–20·4)
1·13
(0·52–2·51)
0·82
(0·48–1·39)
0·92
(0·63–1·34)
India (urban) 1·75
(1·44–2·13)
8·4
(6·4–11·8)
0·84
(0·55–1·28)
0·88
(0·69–1·13)
0·74
(0·58–0·96)
1·16
(0·64–2·13)
57·8
(7·5–inﬁ nity)
0·57
(0·17–1·80)
1·27
(0·66–2·45)
1·05
(0·48–2·28)
India (rural) 1·42
(1·21–1·66)
11·4
(8·2–18·2)
0·54
(0·34–0·86)
0·69
(0·45–1·05)
0·93
(0·80–1·09)
1·05
(0·51–2·18)
18·7
(4·4–inﬁ nity)
2·34
(0·57–9·66)
0·26
(0·05–1·40)
0·73
(0·38–1·38)
Pooled meta-analysis
Meta-analysed 
estimate
1·92
(1·80–2·01)
7·3
(6·4–8·3)
0·84
(0·75–0·93)
0·82
(0·77–0·87)
0·93
(0·89–0·99)
1·92
(1·75–2·12)
7·5
(6·7–8·3)
0·88
(0·73–1·05)
0·83
(0·75–0·90)
1·02
(0·93–0·12)
χ2 test for 
heterogeneity 
(degrees of freedom)
36·6 (10);
p<0·0001
7·8 (10);
p=0·65
11·2 (10);
p=0·34
17·8 (10);
p=0·06
8·7 (9);
p=0·47
7·3 (9);
p=0·61
23·9 (9);
p=0·004
7·8 (9);
p=0·56
Higgins I2 (95% CI) 73% (50–85) 0% (0–60) 11% (0–51) 44% (0–72) 0% (0–62) 0% (0–60) 62% (25–81) 0% (0–62)
Table 6: Prevalence ratios (95% CI) from a Poisson regression for the independent eﬀ ects of age, sex, education, and assets on dementia prevalence
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and 9% (table 3). DSM-IV dementia prevalence was also 
somewhat higher in Cuba (6·3%) and the Dominican 
Republic (4·2%) and substantially lower in rural Peru 
(0·4%) and urban (0·9%) and rural India (0·3%) than in 
other sites, where the prevalence ranged between 2% 
and 4% (table 4).
When we compared the prevalence of DSM-IV 
dementia in 10/66 sites with the consistent, pooled 
estimate from the 12 European sites in the EURODEM 
meta-analysis14 (indirectly standardising for age and sex), 
the prevalence in urban Latin American sites was about 
four-ﬁ fths of that in Europe, that in the Chinese sites was 
just over half, and that in rural Latin American and 
Indian sites only between a quarter and a ﬁ fth (table 5). 
We then compared the prevalence estimates from our 
studies with the relevant region-speciﬁ c prevalence 
estimates from the ADI and Lancet consensus study,6 
indirectly standardising for age (table 5). The DSM-IV 
dementia prevalences from the 10/66 studies, especially 
for rural Latin America and India, were lower than were 
those from the ADI and Lancet consensus study. The 
10/66 dementia prevalences, when patients with 
questionable CDR were excluded, were much closer to 
estimates from the ADI and Lancet consensus study for 
most regions, but still less than half that for rural Latin 
America (table 5). Inclusion of patients with 10/66 
dementia classiﬁ ed as questionable provided the closest 
match for the prevalence from the ADI and Lancet 
consensus study for Latin America and China, but the 
10/66 dementia prevalence in India was then three times 
higher for that region (table 5).
Across all sites, 498 (94%) of 532 patients with DSM-IV 
dementia were also classiﬁ ed as having 10/66 dementia. 
An additional 847 of 1345 cases of 10/66 dementia were 
not conﬁ rmed by DSM-IV criteria. The distribution of 
WHODAS disability scores in those with 10/66 dementia 
that was not conﬁ rmed by DSM-IV dementia criteria was 
intermediate, but scores were much closer to the high 
(more impaired) scores in those with DSM-IV dementia 
than to the low (less impaired) scores in those who did 
not meet either set of criteria (table 7). The interaction 
between 10/66 dementia and DSM-IV dementia was not 
signiﬁ cant in six of the 11 site-speciﬁ c regressions to 
predict WHODAS disability score (table 7), indicating 
that the levels of disability in patients with 10/66 dementia 
not conﬁ rmed by DSM-IV criteria may be similar, at least 
in Peru, Venezuela, urban Mexico, and urban China. 
In a post-hoc analysis, we explored further the 
discrepancies between the prevalence of 10/66 dementia 
and DSM-IV dementia. Although we recorded fairly small 
diﬀ erences between sites and regions in the prevalence of 
objective memory impairment (impairment on two or 
more of three memory tests), we noted substantial regional 
variation in the proportion of patients meeting the cardinal 
DSM-IV A1 criteria (impairment in memory) who also met 
the B criterion (cognitive decline and social or occupational 
impairment): 501/893 (56·1%) in urban Latin American 
sites, 39/68 (57·4%) in urban China, and 25/44 (56·8%) in 
rural China, compared with only 29/98 (29·6%) in rural 
Latin America, 11/36 (30·6%) in urban India, and 11/86 
(12·8%) in rural India. The CSI’D’ informant interview 
RELSCORE is the main source of information that is used 
Mean (SD) WHODAS disability scores Risk ratios (95% CI) from a zero 
inﬂ ated negative binomial regression*
Overall Group 1: no dementia Group 2: 10/66 
dementia not 
conﬁ rmed by DSM-IV
Group 3: DSM-IV 
dementia  
Group 2 vs group 1 Group 3 vs group 2
Cuba 13·4 (20·0) n=2920 9·7 (14·1) n=2600 36·0 (30·2) n=132 48·6 (32·0) n=188 2·34 (2·00–2·75) 1·38 (1·13–1·69)
Dominican Republic 16·5 (20·3) n=1996 13·9 (17·3) n=1757 28·9 (26·9) n=133 43·5 (29·5) n=106 1·60 (1·35–1·89) 1·39 (1·09–1·77)
Venezuela 10·8 (16·4) n=1852 9·2 (13·8) n=1740 32·0 (29·3) n=77 39·9 (30·4) n=35 2·33 (1·86–2·91) 1·13 (0·77–1·65)
Peru
Urban 13·1 (20·6) n=1369 9·5 (15·2) n=1242 47·4 (31·9) n=84 48·5 (31·2) n=43 3·15 (2·54–3·90) 1·00 (0·70–1·42)
Rural 10·4 (14·6) n=550 9·0 (12·0) n=514 29·0 (26·6) n=34 62·5 (17·7) n=2 2·54 (1·84–3·51) 1·80 (0·55–5·86)
Mexico
Urban 10·0 (17·3) n=1000 8·1 (14·3) n=907 25·4 (25·4) n=52 32·8 (33·0) n=41 1·92 (1·41–2·62) 1·23 (0·77–1·97)
Rural 11·1 (19·1) n=1000 9·1 (16·2) n=913 26·2 (29·9) n=65 47·7 (31·8) n=22 1·87 (1·41–2·46) 1·61 (0·98–2·64)
China
Urban 8·1 (20·1) n=1150 4·6 (13·4) n=1071 46·4 (33·4) n=44 65·6 (30·8) n=35 2·26 (1·68–3·02) 1·36 (0·91–2·02)
Rural 8·0 (14·6) n=1000 6·0 (10·1) n=945 31·9 (24·8) n=32 55·9 (31·5) n=23 2·09 (1·67–2·61) 1·82 (1·30–2·55)
India
Urban 10·5 (15·4) n=1001 9·5 (14·2) n=926 20·2 (18·9) n=66 46·6 (34·2) n=9 1·65 (1·29–2·11) 2·22 (1·17–4·21)
Rural 28·3 (18·3) n=999 26·4 (16·6) n=891 41·8 (21·5) n=100 72·2 (23·0) n=8 1·46 (1·30–1·65) 1·69 (1·06–2·69)
WHODAS=WHO Disability Assessment Schedule. *Model also includes the eﬀ ects of sex and education (parameters not shown).
Table 7: Distribution of WHODAS disability scores by dementia status and site, and the eﬀ ects of dementia (main eﬀ ect of 10/66 dementia, modiﬁ ed by 
DSM-IV dementia) on WHODAS score
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to establish the DSM-IV dementia B criterion. We used a 
negative binomial regression model (table 8) to identify its 
correlates. We controlled for objective evidence of memory 
impairment (number of impaired memory tests), as well 
as participant and informant characteristics that could be 
sources of methodological bias, and ﬁ tted a site or region 
by objective memory impairment interaction term. In the 
absence of objective memory impairment, RELSCOREs 
were highest in urban Latin America (table 8). In these 
sites, we recorded a strong association between objective 
memory impairment and RELSCORE. Site or region by 
objective memory impairment interaction terms indicated 
that this association was strongest in China, but 
signiﬁ cantly weaker in rural Latin America, urban India 
and, particularly, rural India than in the urban Latin 
American sites (table 8). RELSCOREs were also lower for 
male participants, those considered to be head of 
household, or those who were better educated, and were 
higher for older participants (table 8). Male informants 
tended to report less impairment, as did those who did not 
live in the same household as the participant, and those 
who were friends or neighbours rather than relatives of the 
participant (table 8).
Discussion
We have shown that the prevalence of DSM-IV dementia 
in urban Latin America is similar to that previously 
recorded in Europe and other developed-country settings. 
However, consistent with other reports from less 
developed regions,2,3 the prevalence of DSM-IV dementia 
in rural Latin America and in India was very low—a 
quarter or less than that typically seen in Europe.14 The 
prevalence of 10/66 dementia, with use of our 10/66 
cross-culturally validated and education-fair algorithm,12 
was more homogenous (although still somewhat higher 
in the urban Latin American sites), and much higher than 
that of DSM-IV dementia, especially in the least developed 
sites. For both dementia outcomes, the eﬀ ect of age on 
prevalence (doubling with every 7·5-year increment in 
age) is attenuated with respect to the doubling with every 
4–6 years that is typically seen in developed-country 
studies.14,25 This ﬁ nding could be explained by a higher 
associated mortality at advanced age in less-developed 
settings; studies from Nigeria26 and Brazil27 have suggested 
especially high mortality risks for people with dementia.
This is the ﬁ rst comparative paper from the 10/66 
Dementia Research Group’s continuing programme of 
population-based studies in Latin America, India, China, 
and Africa. As this work evolves, we hope to give a clearer 
understanding of the distribution, determinants, and 
public-health eﬀ ect of the disorder, particularly in regions 
where little research has been published.
The whole catchment area sampling strategy enabled us 
to foster links with local communities, improving response 
and helping with follow-up; however, prevalence estimates 
might not be generalisable beyond these and similar 
districts. Our one-phase dementia diagnostic assessment 
has several advantages compared with the two-phase 
approach that is used in most previous studies.28 Attrition 
is pronounced between the ﬁ rst and second phase;29 
participants with probable dementia are likely to refuse, 
move away, or die, leading to informative censoring. The 
problem is compounded when no random sample of 
screen negatives is selected for second-phase assessment 
with the tacit assumption of perfect sensitivity for the 
screening measure.28,30 Our participant and informant 
assessments were generally well tolerated, as shown by 
high levels of participation; non-response bias should 
therefore be small, but we have little information about 
non-responders to clarify this notion. We are also relatively 
well-placed to make valid comparisons of prevalence 
between regions. All sites adopted the same core protocol 
and assessments. The 10/66 dementia algorithm was 
carefully validated in 25 LMIC sites,12 including all those 
in this report. We have also fully operationalised and 
computerised the DSM-IV dementia criterion, and 
validated this and our 10/66 dementia diagnosis against 
clinician diagnosis in our Cuban centre.20
How can the discrepancy between the prevalence of 
10/66 dementia and DSM-IV dementia be explained? In 
our 10/66 dementia validation,12 sensitivity and speciﬁ city 
Relative risk (95% CI) p value
Characteristics of informant
Relation to participant (friend or neighbour vs other) 0·73 (0·65–0·81) <0·0001
Male sex 0·81 (0·77–0·85) <0·0001
Not living in same household 0·88 (0·83–0·94) 0·00014
Characteristics of participant
Age (per 5-year age group) 1·22 (1·19–1·24) <0·0001
Male sex 0·86 (0·82–0·91) <0·0001
Educational level 0·89 (0·87–0·91) <0·0001
Considered head of household 0·89 (0·84–0·93) <0·0001
Main eﬀ ect of number of memory tests impaired (per additional impaired 
test), in urban Latin America*
1·83 (1·78–1·88) <0·0001
Main eﬀ ect of site/region (when no memory tests impaired)
Urban Latin America 1 (reference)
Rural Latin America 0·79 (0·72–0·85) <0·0001
Urban China 0·48 (0·43–0·54) <0·0001
Rural China 0·17 (0·14–0·20) <0·0001
Urban India 0·52 (0·46–0·58) <0·0001
Rural India 0·61 (0·56–0·66) <0·0001
Interaction of site/region with number of memory tests impaired
Urban Latin America 1 (reference)
Rural Latin America 0·83 (0·76–0·90) <0·0001
Urban China 1·40 (1·28–1·53) <0·0001
Rural China 1·46 (1·29–1·65) <0·0001
Urban India 0·82 (0·72–0·93) 0·002
Rural India 0·66 (0·61–0·71) <0·0001
Negative binomial regression; n=14 783. *To obtain the estimated relative risk for the eﬀ ect of number of memory 
tests impaired for another site or region, multiply the main eﬀ ect in urban Latin America by the relevant interaction 
term—eg, for rural India: 1·83×0·66=1·21.
Table 8: Independent correlates of community screening instrument for dementia informant report of 
intellectual and functional decline (RELSCORE) 
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were both excellent against the gold standard of a local 
clinician’s DSM-IV diagnosis. However, the false positive 
rate, which varied between 1% and 10% across regions 
and levels of education, might be one factor accounting 
for the higher prevalence of 10/66 dementia. The higher 
severity proﬁ le of DSM-IV dementia cases that we re-
corded was expected, since the criteria prioritise re liability 
by restricting the diagnosis to more severe and in-
controvertible cases; several domains of cognitive function 
must be aﬀ ected, each with clear evidence of social or 
occupational impairment. DSM-IV dementia is thus the 
narrower and more speciﬁ c criterion. The key question is 
whether DSM-IV dementia is also a sensitive criterion, or 
whether 10/66 dementia might be better at detecting those 
with milder and recent onset disease. In our Cuban centre, 
10/66 dementia corresponded more closely with dementia 
diagnoses made by the Cuban clinical interviewer than 
did DSM-IV dementia, which selectively missed mild and 
moderate cases.20 A similar ﬁ nding was reported from the 
Canadian Study of Health and Ageing.31 
DSM-IV criteria have been criticised for the primacy 
accorded to memory impairment (which is not an early 
feature in some dementia subtypes) and for the lack of 
speciﬁ city of the secondary cognitive criteria.32 Our 
ﬁ nding that those with a 10/66 dementia diagnosis that 
was not conﬁ rmed by the DSM-IV criterion were 
consistently disabled compared with those without 
disease, and that they could not be distinguished in that 
respect from patients with DSM-IV dementia in six of our 
11 sites, is an important construct validation of the 10/66 
dementia diagnosis; the WHODAS disability scale was 
not used to establish either dementia diagnostic outcome. 
Overall we believe that we have good empirical evidence 
that the DSM-IV dementia criterion might lack speciﬁ city, 
and hence underestimate true dementia prevalence.
Underestimation by the DSM-IV dementia criterion was 
a particular issue in rural and less-developed sites. Our 
data suggest that this underestimation might be 
attributable to cultural eﬀ ects on informant reports of 
intellectual decline and social or occupational impair ment, 
speciﬁ cally a much weaker correlation between objective 
evidence of memory impairment and informant reports 
in less-developed settings. Several possible mechanisms 
might be implicated. First, our cognitive tests could be 
biased, overestimating cognitive impairment in these 
settings. However, this notion seems unlikely in view of 
the small regional eﬀ ects on test performance in our pilot 
study, after controlling for the more prominent inﬂ uences 
of age, education, and dementia.12 For our DSM-IV 
algorithm, cognitive impairment is deﬁ ned with reference 
to age-speciﬁ c and education-speciﬁ c test norms from the 
pilot study.20 Second, objective cognitive impairment 
might be less likely to lead to noticeable impairment in 
the per formance of normal social roles, because of the 
high levels of instrumental support that are routinely 
provided to all older people, especially in the early stages 
of dementia; more attention might need to be given to 
developing culturally relevant assessments to detect the 
results of early intellectual decline. Third, impairment or 
decline might have been noted by informants, but they 
could have been reluctant to disclose this information 
because of the culture of respect towards elderly people. 
This tenet accords with our ﬁ nding of lower reported 
scores by informants for heads of household and male 
participants. Last, impairment or decline might have been 
noted, but attributed to a normal ageing process33,34 and 
hence not worthy of mention in view of the implicit focus 
of the assessments on abnormality. 
The merits of pathologising the last three of these 
scenarios could be debated. Is there a point to labelling 
someone as having dementia, if their relatives do not 
acknowledge a problem? However, our data suggest 
substantial associated disability, and the quality of life of 
the elderly person will probably be impaired. Our pilot 
studies also suggested high levels of caregiver strain which 
were exacerbated by little understanding of the nature of 
the underlying disorder.33,35,36 Our post-hoc analysis 
suggests that the accuracy of reports from informants 
might be improved by selecting female informants (who 
are mostly responsible for providing care) who are related 
to and living with the participant. An important rationale 
for dementia diagnosis is that it alerts patients, clinicians, 
and carers to the likelihood of progression. The predictive 
validity of the 10/66 dementia diagnosis will be tested in 
the 10/66 incidence phase. Patients with true dementia 
would have progressed or died, whereas others will have 
been misclassiﬁ ed. Those that progress are likely to need 
assistance, but, at present are poorly served by health and 
social-care systems that fail to meet their needs.37 Accurate 
estimation of the true population burden is the ﬁ rst 
important step in addressing this problem.
Our conclusion is that the DSM-IV dementia criterion 
might substantially underestimate the true prevalence of 
dementia, especially in least developed regions, because 
of diﬃ  culties in deﬁ ning and ascertaining decline in 
intellectual function and its consequences. We believe 
that our methods have drawn attention to a substantial 
prevalence of dementia that might have been missed. 
Prevalence diﬀ erences between developed and developing 
countries might not be as large as previously thought. 
Our new estimates are broadly consistent with recent 
expert consensus estimates of regional prevalence for 
Latin America and China, but numbers aﬀ ected in India 
might have been substantially underestimated.6
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